Physician profile
David Wayne Polly
NPI 1669483046
$3,308,167.17
in general payments reported to CMS, 2019-2025
15 companies · $1.1M in 2025
The $1.1M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $112K · 2021: $280K · 2022: $432K · 2023: $620K · 2024: $736K · 2025: $1.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.7M · Consulting Fee: $621K · Travel and Lodging: $64K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,703,540.36 |
| Consulting Fee | $620,916.34 |
| Travel and Lodging | $64,089.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,150.00 |
| Food and Beverage | $11,188.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $3,087,516.09 | 2019-2025 | |
| Medtronic, INC. | $169,006.63 | 2021-2025 | Unid_pass, Catalyft Pl Expandable Interbody System, O-Arm |
| Globus Medical, INC. | $49,886.50 | 2019-2024 | Creo, External Fixation, Creo 5.5 |
| Alphatec Spine, INC | $448.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $203.94 | 2023 | Exparel, Iovera, Zilretta |
| Carlsmed, INC. | $160.18 | 2025 | Aprevo |
| Medical Device Business Services, INC. | $142.85 | 2022 | |
| Depuy Synthes Sales INC. | $125.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $122.85 | 2021 | |
| Medtronic USA, INC. | $122.20 | 2019-2020 | |
| Nuvasive, INC. | $117.61 | 2019 | |
| Stryker Corporation | $114.88 | 2019 | |
| Kuros Biosciences USA, INC | $95.24 | 2023 | |
| Orthofix Medical, INC. | $55.20 | 2025 | Osteostrand Plus |
| Choice Spine, LLC | $50.00 | 2025 | Thunderbolt Minimally Invasive Pedicle Screw Systems, Stratofuse, Blackhawk Cervical Spacer System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Polly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.